Skip to main content
. 2019 Apr 30;35(2):83–93. doi: 10.3393/ac.2019.04.22.1

Table 2.

Operative data and pathologic outcomes

Variable ypT0N0 (n = 111) Residual disease (n = 469) P-value
Operative name 0.241
 Low anterior resection 64 (57.7) 242 (51.6)
 Ultralow anterior resection 40 (36.0) 189 (40.3)
 Abdominoperineal resection 7 (6.3) 38 (8.1)
Operative time (min) 185 (93–528) 200 (50–740) 0.392
Surgical approach 0.260
 Open 75 (67.6) 350 (74.6)
 Laparoscopy 34 (30.6) 112 (23.9)
 Robot 2 (1.8) 7 (1.5)
Postoperative hospital stay (day) 9 (5–22) 9 (1–57) 0.624
Pathologic AJCC
 Stage 0 111 (100) N/A
 Stage I N/A 151 (32.2)
 Stage II N/A 162 (34.5)
 Stage III N/A 156 (33.3)
Pathologic T classification
 ypT0 111 (100) 4 (0.9)
 ypT1 N/A 36 (7.7)
 ypT2 N/A 150 (32.0)
 ypT3 N/A 273 (58.2)
 ypT4 N/A 6 (1.3)
Pathologic N classification
 ypN0 111 (100) 313 (66.7)
 ypN1 N/A 124 (26.4)
 ypN2 N/A 32 (6.8)
Median No. of harvested LNs (range) 13 (1–34) 13 (1–43) 0.411
Circumferential resection margin 0.144
 Negative 0 (0) 13 (2.8)
 Positive 111 (100) 456 (97.2)

Values are presented as number (%) or median (range).

AJCC, American Joint Committee on Cancer; LNs, lymph nodes.